We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWKZ
8976
DELISTED
Hawks Acquisition Corp
HWKZ
$6K ﹤0.01%
600
MRAI
8977
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
$6K ﹤0.01%
867
+708
+445% +$6.46K
FNCH
8978
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$6K ﹤0.01%
40
-133
-77% -$30.7K
BLCM
8979
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$6K ﹤0.01%
2,671
-4,303
-62% -$7K
TRAQ
8980
DELISTED
Trine II Acquisition Corp.
TRAQ
$6K ﹤0.01%
600
IPVI
8981
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$6K ﹤0.01%
600
-700
-54% -$6.81K
PANA
8982
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$6K ﹤0.01%
643
-225
-26% -$2.18K
DTEA
8983
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$6K ﹤0.01%
2,194
-188
-8% -$578
AMYT
8984
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$6K ﹤0.01%
+759
New +$6.85K
MSDAW
8985
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$6K ﹤0.01%
7,684
+6,212
+422% +$5.32K
CRZN
8986
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$6K ﹤0.01%
+600
New +$5.83K
LDHAU
8987
DELISTED
LDH Growth Corp I Units
LDHAU
$6K ﹤0.01%
621
+10
+2% +$98
GWII
8988
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
$6K ﹤0.01%
613
-1,130
-65% -$11.1K
AGGRU
8989
DELISTED
Agile Growth Corp Units
AGGRU
$6K ﹤0.01%
+600
New +$5.91K
LOKM
8990
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$6K ﹤0.01%
572
LHDX
8991
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$6K ﹤0.01%
1,619
-153
-9% -$751
ANAC.U
8992
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
$6K ﹤0.01%
629
LGAC
8993
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$6K ﹤0.01%
626
+1
+0.2% +$10
DTRTU
8994
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
$6K ﹤0.01%
594
+100
+20% +$1.01K
ASAX
8995
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$6K ﹤0.01%
579
-1,340
-70% -$13.1K
CLAS
8996
DELISTED
Class Acceleration Corp.
CLAS
$6K ﹤0.01%
618
-1
-0.2% -$10
HIL
8997
DELISTED
Hill International, Inc. Common Stock
HIL
$6K ﹤0.01%
3,407
+1,411
+71% +$2.68K
HTGM
8998
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$6K ﹤0.01%
333
+146
+78% +$4.68K
GTPA
8999
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
$6K ﹤0.01%
600
TSPQ.U
9000
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
$6K ﹤0.01%
600
+300
+100% +$2.95K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.